Core Viewpoint - Eos Energy Enterprises, Inc. is under investigation for potential violations of federal securities laws due to misleading statements regarding its revenue growth and manufacturing efforts [1][3]. Group 1: Investigation Details - The investigation focuses on whether Eos made false and misleading statements to investors about its near-term revenue growth and the execution of its manufacturing initiatives [3][9]. - Eos manufactures zinc-based long-duration battery energy storage systems aimed at supporting renewable energy and grid reliability [2]. Group 2: Financial Performance - Eos reported a significant net loss of approximately $970 million for fiscal year 2025, which was attributed to high spending on scaling manufacturing operations and inefficiencies [4]. - The company disclosed that its full-year 2025 revenue fell short of previously reaffirmed guidance, and it issued weaker-than-expected revenue guidance for 2026 due to slower production progress [4]. Group 3: Stock Market Reaction - Following the announcement of its financial results and guidance, Eos's stock price dropped over 39% on February 26, 2026 [5][9].

Core Viewpoint - Eos Energy Enterprises, Inc. is under investigation for potential violations of federal securities laws, particularly concerning misleading statements about its revenue growth and manufacturing capabilities [1][3]. Group 1: Investigation Details - The investigation is led by Bleichmar Fonti & Auld LLP, focusing on whether Eos made false and misleading statements to investors regarding its near-term revenue growth and the execution of its manufacturing efforts [3][8]. - Eos manufactures zinc-based long-duration battery energy storage systems aimed at supporting renewable energy and grid reliability [2]. Group 2: Financial Performance and Stock Impact - Eos reported a significant net loss of approximately $970 million for fiscal year 2025, with revenue falling short of previously reaffirmed guidance [4]. - The company attributed its poor performance to high spending on scaling manufacturing operations, including inefficiencies and automation-related costs [4]. - Following the announcement of disappointing results and weaker-than-expected revenue guidance for 2026, Eos's stock price dropped over 39% on February 26, 2026 [5][8].

Core Viewpoint - A securities class action lawsuit has been filed against Varonis Systems, Inc. and its executives, with a lead plaintiff deadline approaching on March 9, 2026, focusing on allegations of concealed issues in the company's transition to a Software-as-a-Service (SaaS) model [1][4]. Group 1: Allegations and Lawsuit Details - The lawsuit claims that Varonis executives misrepresented the company's ability to transition to a SaaS model while failing to disclose significant renewal challenges in its Federal vertical and legacy on-premises business [2][5]. - Following a disclosure on October 28, 2025, regarding difficulties in converting existing customers to the SaaS model, Varonis reported a 63.9% year-over-year decline in term license revenue and reduced its Annual Recurring Revenue (ARR) outlook, leading to a 48% drop in stock price, equating to a loss of approximately $3.8 billion in market value [3][9]. Group 2: Financial Impact and Stock Performance - The stock price of Varonis fell from $63.00 to $32.34 in a single day, reflecting a nearly 50% loss in shareholder value following the negative disclosures [9]. - The company significantly reduced its Q4 revenue and full-year ARR guidance after the disappointing Q3 performance, which contradicted previous optimistic statements about growth [9]. Group 3: Investor Actions and Support - Hagens Berman is actively encouraging investors who suffered losses during the class period from February 4, 2025, to October 28, 2025, to come forward and submit their claims [4][7]. - The firm is also advising potential whistleblowers with non-public information about Varonis to consider participating in the investigation or the SEC Whistleblower program, which offers rewards for original information leading to successful recoveries [10].

Core Viewpoint - Hagens Berman is notifying investors about a pending securities class action against Fermi Inc. related to misrepresentations regarding its Project Matador and the stability of its primary tenant [1][3]. Allegations - The litigation claims that Fermi misrepresented the demand for its Project Matador AI data center, leading to inflated expectations [3][8]. - The complaint highlights that Fermi's IPO materials allegedly created a misleading picture of demand to secure financing [4][8]. - It is alleged that Fermi's registration statement overstated the actual demand for Project Matador's capacity to attract higher valuations [8]. Key Events - On December 12, 2025, Fermi announced the termination of a $150 million Advance in Aid of Construction Agreement by its first tenant, which led to a nearly 34% drop in stock price [3][8]. - Following the announcement, Fermi's stock price fell to as low as $8.59 per share, representing a 59% decline from the IPO price of $21.00 per share [8]. Class Action Details - The class action lawsuit seeks to represent investors who purchased Fermi shares during the October 2025 IPO and those who acquired shares between October 1, 2025, and December 11, 2025 [8]. - The lead plaintiff deadline for the class action is set for March 6, 2026 [1][7].

Core Viewpoint - The Enphase Energy class action lawsuit alleges that the company and its executives made misleading statements regarding their financial and operational prospects, leading to significant stock price declines following the disclosure of negative financial results [3][4]. Group 1: Class Action Details - The class action lawsuit is titled Tripathi v. Enphase Energy, Inc., and it involves purchasers of Enphase Energy securities from April 22, 2025, to October 28, 2025 [1]. - Investors have until April 20, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit claims that Enphase Energy overstated its ability to manage channel inventory and mitigate the effects of the termination of the Residential Clean Energy Credit [3]. Group 2: Financial Impact - On October 28, 2025, Enphase Energy reported that elevated channel inventory would lead to lower battery storage shipments in Q4 2025 and that the expiration of the 25D Credit would negatively impact revenues in Q1 2026 [4]. - Following this announcement, Enphase Energy's stock price fell by more than 15% [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Enphase Energy securities during the class period to seek lead plaintiff status [5]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [6]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, including the largest securities class action recovery in history [6].

Core Viewpoint - Glancy Prongay Wolke & Rotter LLP has initiated an investigation into Camping World Holdings, Inc. regarding potential violations of federal securities laws affecting investors [1] Company Summary - The investigation is on behalf of investors who may have incurred losses related to Camping World Holdings, Inc. (CWH) [1]

NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Corcept Therapeutics Incorporated (NASDAQ: CORT) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Corcept securities between October 31, 2024 and December ...

NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Franklin BSP Realty Trust, Inc. (NYSE: FBRT) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired FBRT securities between November 5, 2024 and February 11, 202 ...

Core Viewpoint - Agilon Health, Inc. (AGL) is facing a securities fraud class action lawsuit due to misleading statements and failure to disclose adverse facts about its business, leading to significant financial losses for investors [1]. Group 1: Lawsuit Details - The deadline for investors to participate as lead plaintiffs in the class action lawsuit is March 2, 2026 [1]. - The class period for the lawsuit is from February 26, 2025, to August 4, 2025, during which agilon's stock price fell by $0.93, or 51.5%, closing at $0.88 per share on August 5, 2025 [1]. - The lawsuit alleges that agilon's management made materially false statements and failed to disclose significant risks, including unrealistic guidance for 2025 and overstated financial impacts from strategic actions [1]. Group 2: Financial Performance - On August 4, 2025, agilon reported second quarter 2025 financial results that missed estimates and announced the suspension of its 2025 guidance due to leadership changes and market uncertainties [1]. - The departure of the President, CEO, and Director was classified as a termination without cause, which contributed to the company's stock price decline [1].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Kyndryl Holdings, Inc. for alleged material misstatements and omissions regarding its financial practices and internal controls during the specified class period from August 7, 2024, to February 9, 2026 [2][4][7]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Eastern District of New York, under the case caption Brander v. Kyndryl Holdings, Inc., et al, Case No. 1:26-cv-00782 (E.D.N.Y.) [2]. - Investors have until April 13, 2026, to file for lead plaintiff status [2][7]. - Key allegations include that Kyndryl's financial statements were materially misstated, and the company lacked adequate internal controls, which led to an inability to timely file its quarterly report for the quarter ended December 31, 2025 [4][7]. Group 2: Stock Performance and Impact - On February 9, 2026, Kyndryl announced the immediate departure of its CFO and General Counsel, which surprised investors and led to a significant stock price drop of over 54%, from $23.49 on February 6, 2026, to $10.59 on February 9, 2026 [5]. - The company disclosed that it is reviewing its cash management practices and anticipates reporting material weaknesses in its internal control over financial reporting [5]. Group 3: Investor Actions - Investors who purchased Kyndryl securities and incurred losses are encouraged to contact Kessler Topaz Meltzer & Check, LLP for recovery options at no cost [3][7]. - Investors may seek to be appointed as a lead plaintiff representative of the class by the deadline of April 13, 2026, or may choose to remain an absent class member [9].